Inventor
Ling Yang
Inventor
Lianyungang, CN
Overview
Patents· 25 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes25%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
C07DHeterocyclic compounds25%
C07BGeneral methods of organic chemistry4%
C02FTreatment of water, waste water, sewage, or sludge3%
G01NInvestigating or analysing materials by determining their chemical or physical properties3%
B01DSeparation1%
C07KPeptides1%
C08FMacromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds1%
C09BOrganic dyes or closely-related compounds for producing dyes, e.g. pigments1%
PatentTitleYear
11,102,796Information transmission processing method and device, node, storage medium and processor202110,829,401Apparatus and method for treating waste water containing ammonium salts202010,829,492Amino pyrazolopyrimidine compound used as neurotrophic factor tyrosine kinase receptor inhibitor202010,815,132Apparatus and method for treating waste water containing ammonium salts202010,780,091TLR7 agonist maleate salt, crystalline forms C, D and E thereof, preparation methods and uses of maleate salt and crystalline forms202010,766,961Anti-VEGFR2 antibody therapy for hepatocellular carcinoma202010,683,296TLR7 agonist trifluoroacetate salt and crystalline form B thereof, preparation methods and uses202010,676,4787-(thiazol-5-yl) pyrrolopyrimidine compound as TLR7 agonist202010,654,856Method for preparing pyrrolo[3,2-D]pyrimidine compound, and intermediates thereof202010,561,657Pyrrolopyrimidine compound202010,561,647Use of quinoline derivatives for treating oesophageal cancer and treatment method, pharmaceutical composition and kit thereof202010,555,949Pyrrolopyrimidine compounds used as TLR7 agonist202010,442,811Crystal form A of 2-butoxy-7-(4-(pyrrolidin-1-ylmethyl)benzyl)-5H-pyrrolo[3,2-D] pyrimidin-4-amine, preparation process and use thereof201910,329,277N-(2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxy-5-((4-(3-methyl-2-OXO-2,3-dihydro-1h-benzo[d]imidazol-1-yl)pyrimidin-2-yl)amino)phenyl)acrylamide hydrochloride as an inhibitor of epidermal growth factor receptor activity201910,307,412Quinoline derivative against non-small cell lung cancer201910,183,017Methods and uses of quinoline derivatives in the treatment of soft tissue sarcomas and pharmaceutical compositions for treatment of same201910,155,775Substituted amino six-membered saturated heteroalicycles as long-acting DPP-IV inhibitors201810,035,792Resorcinol derivative as HSP90 inhibitor20189,968,597Methods and uses of quinoline derivatives in the treatment of soft tissue sarcomas and pharmaceutical compositions for treatment of same20189,962,388Pyrrolopyrimidine compounds used as TLR7 agonist20189,340,821'Specific fluorescent probe based on albumin pseudo-esterase hydrolysis reaction and use thereof'20169,238,643'Amide compounds'20168,661,281'USB HUB and power management method thereof'20147,592,367'Compounds from Garcinia hanburyi, their use in treating cancer and method of separating epimers thereof'20097,388,060'Catalyst component for olefin (co)polymerization, preparation thereof, a catalyst comprising the same and use thereof'2008Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2009–2016Based in Dalian, CN· patent location history
2018–2020Patents assigned to CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD (16)· patent assignee history
2018–2020Patents assigned to CENTAURUS BIOPHARMA CO LTD (4)· patent assignee history
2018–2020Patents assigned to LIANYUNGANG RUNZHONG PHARMACEUTICAL CO LTD (4)· patent assignee history
2018–2019Patents assigned to ADVENCHEN LABORATORIES NANJING LTD (2)· patent assignee history
2018–2020Based in Lianyungang, CN· patent location history
2018–2020Based in Jiangsu, CN· patent location history
2020Patents assigned to CHINA PETROLEUM & CHEM CORP (2)· patent assignee history
2020Based in Shandong, CN· patent location history
2021Based in Shenzhen, CN· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD | 16 | 2018–2020 |
| CENTAURUS BIOPHARMA CO LTD | 4 | 2018–2020 |
| LIANYUNGANG RUNZHONG PHARMACEUTICAL CO LTD | 4 | 2018–2020 |
| ADVENCHEN LABORATORIES NANJING LTD | 2 | 2018–2019 |
| CHINA PETROLEUM & CHEM CORP | 2 | 2020 |
Locations
| Location | Patents | Span |
|---|---|---|
| Lianyungang, CN | 12 | 2018–2020 |
| Jiangsu, CN | 4 | 2018–2020 |
| Shandong, CN | 2 | 2020 |
| Dalian, CN | 2 | 2009–2016 |
| Shenzhen, CN | 1 | 2021 |